PPW
HBIO icon

Pasadena Private Wealth’s Harvard Bioscience HBIO Stock Holding History

Pasadena Private Wealth’s Portfolio HBIO Stock Details HBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-4,500
Closed -$30.1K – 285
2025
Q4 		$30.1K Sell
4,500
-19,891
-82% -$118K ﹤0.01% 244
2025
Q3 		$107K Hold
24,391
– – 0.02% 200
2025
Q2 		$108K Buy
24,391
+4,587
+23% +$19.2K 0.02% 188
2025
Q1 		$112K Hold
19,804
– – 0.02% 180
2024
Q4 		$418K Hold
19,804
– – 0.09% 101
2024
Q3 		$533K Hold
19,804
– – 0.11% 82
2024
Q2 		$564K Buy
19,804
+2,555
+15% +$89.6K 0.13% 74
2024
Q1 		$731K Hold
17,249
– – 0.17% 63
2023
Q4 		$923K Hold
17,249
– – 0.23% 50
2023
Q3 		$742K Hold
17,249
– – 0.22% 38
2023
Q2 		$947K Buy
17,249
+3,826
+29% +$210K 0.27% 35
2023
Q1 		$564K Hold
13,423
– – 0.16% 48
2022
Q4 		$372K Hold
13,423
– – 0.11% 59
2022
Q3 		$344K Hold
13,423
– – 0.12% 59
2022
Q2 		$483K Buy
13,423
+1,693
+14% +$76.4K 0.17% 45
2022
Q1 		$728K Buy
11,730
+140
+1% +$8.28K 0.24% 38
2021
Q4 		$817K Buy
11,590
+815
+8% +$57.9K 0.27% 40
2021
Q3 		$752K Buy
10,775
+407
+4% +$32.4K 0.26% 34
2021
Q2 		$864K Buy
10,368
+3,218
+45% +$228K 0.3% 35
2021
Q1 		$390K Buy
7,150
+592
+9% +$28.8K 0.14% 52
2020
Q4 		$281K Buy
6,558
+593
+10% +$22.1K 0.11% 58
2020
Q3 		$180K Buy
5,965
+392
+7% +$13.2K 0.07% 68
2020
Q2 		$173K Buy
5,573
+2,000
+56% +$53.9K 0.07% 63
2020
Q1 		$83K Buy
3,573
+1,033
+41% +$28K 0.03% 66
2019
Q4 		$77K Hold
2,540
– – 0.03% 61
2019
Q3 		$78K Buy
+2,540
New +$63.1K 0.04% 56

Other funds holding HBIO

WCM
Weber Capital Management San Francisco, California $100M AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CCM
Corsair Capital Management New York $673M AUM 109.99% 1-Year Est. Return
MIM
Meros Investment Management Dallas, Texas $231M AUM 35.94% 1-Year Est. Return
NCNMGF
Nano-Cap New Millennium Growth Fund Staten Island, New York $107M AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Pasadena Private Wealth's HBIO Position: Q1 2026 in Review

Pasadena Private Wealth sold out of Harvard Bioscience (HBIO) in Q1 2026, closing a stake of 4,500 shares — an estimated $30.1K sold.

Pasadena Private Wealth first reported a position in HBIO in Q3 2019 and held it in 26 quarters. The position peaked at $947K in Q2 2023. 36 funds tracked by Wall St. Rank hold HBIO as of Q1 2026.

  • Pasadena Private Wealth reported no remaining Harvard Bioscience position as of Q1 2026 after selling out during the quarter.
  • Pasadena Private Wealth sold 4,500 Harvard Bioscience shares in Q1 2026, an estimated $30.1K.
  • Pasadena Private Wealth first reported a position in Harvard Bioscience in Q3 2019 and held it in 26 quarters.
  • Pasadena Private Wealth's Harvard Bioscience position peaked at $947K in Q2 2023.
  • 36 funds tracked by Wall St. Rank held Harvard Bioscience as of Q1 2026.

Based on Pasadena Private Wealth's 13F filing for Q1 2026, filed 22 Apr 2026.